Preclinical development of ADCT-211, a novel pyrrolobenzodiazepine dimer-based antibody-drug conjugate targeting solid tumors expressing IL13RA2

被引：0

|

作者：

Zammarchi, Francesca

Havenith, Karin

Leatherdale, Ben

Roberts, Britanny

Montolio, Lara

Patel, Afroze

Janghra, Narinder

Alves, Pedro

Zaitseva, Kristina

Kirby, Cecile Oblette Ian

de Haan, Lolke

van Berkel, Patrick H.

机构：

来源：

CANCER RESEARCH | 2023年 / 83卷 / 07期

关键词：

D O I：

10.1158/1538-7445.AM2023-1604

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1604

引用

收藏

页数：3

相关论文

共 43 条

[41] Phase 1 dose escalation study of XMT-1536, a novel NaPi2b-targeting antibody-drug conjugate (ADC), in patients (pts) with solid tumors likely to express NaPi2b.
Tolcher, Anthony W.
Ulahannan, Susanna Varkey
Papadopoulos, Kyriakos P.
Edenfield, William Jeffery
Matulonis, Ursula A.
Burns, Timothy F.
Mosher, Rebecca
Fielman, Barbara
Hailman, Eric
Burris, Howard A.
Moore, Kathleen N.
Hamilton, Erika Paige
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[42] BCG033, a novel bispecific antibody-drug conjugate targeting PTK7 and TROP2, demonstrates preclinical efficacy against triple-negative breast cancer and other solid tumor xenografts
Yao, Sufei
Shang, Chengzhang
An, Gao
Guo, Chaoshe
An, W. Frk
Yang, Yi
CANCER RESEARCH, 2024, 84 (06)
[43] Preclinical efficacy and safety of M9140, a novel antibody-drug conjugate (ADC) with topoisomerase 1 (TOP1) inhibitor payload targeting carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)-expressing colorectal tumors
Raab-Westphal, Sabine
Hart, Felix
Sloot, Willem
Shan, Min
Rasche, Nicolas
Amendt, Christiane
Anderl, Jan
CANCER RESEARCH, 2024, 84 (06)

← 1 2 3 4 5 →